Restricting insulin doses to lose weight increases chances of complications, study finds
WEDNESDAY, Feb. 27 (HealthDay News) -- Women with type 1 diabetes who take less insulin than they should to try to lose weight triple their risk of dying compared to women who do not skip insulin doses, a new study finds.
"This is a very important women's health issue in diabetes," said Ann E. Goebel-Fabbri, lead author of a study in the March issue of Diabetes Care. "It happens at shockingly high rates, and, if we can detect this problem sooner and earlier, one would hope that we could direct patients to effective treatment."
Insulin treatment has been linked to weight gain; this practice of restricting insulin is referred to as "diabulimia," and is a dangerous way to shed pounds quickly. Previous studies have shown that women with diabetes are almost 2.5 times more likely to develop an eating disorder than women without diabetes. Research also suggests that diabulimia can increase the risk of complications such as foot and vision problems, along with kidney damage, but there has been little research on mortality.
People with type 1 diabetes have completely lost the ability to produce their own insulin, the hormone necessary to usher glucose into cells, where it is stored for energy. Regular injections of insulin essentially replace what the body used to produce naturally.
But shortchanging insulin doses means glucose levels are not controlled and, as the landmark Diabetes Control and Complications Trial established, persistently high blood glucose levels lead to serious complications, including eye and kidney trouble, and even death.
"Insulin is the hormone that allows the transport of glucose from the bloodstream into cells for use, so either the sugar gets used then and there for energy or it gets stored for later use," explained Goebel-Fabbri, a psychologist and investigator in the Section on Beh
All rights reserved